Department of Obstetrics and Gynecology, University Witten-Herdecke, Department of Obstetrics and Gynecology, Academic Hospital Cologne Weyertal University of Cologne, Germany.
Department of Obstetrics and Gynecology Academic Hospital Cologne Weyertal University of Cologne, Germany.
Ginekol Pol. 2022;93(8):614-619. doi: 10.5603/GP.a2022.0042. Epub 2022 Jul 27.
To show the advantages of transcervical radiofrequency ablation (TRFA) in high-risk patients with bleeding disorder.
It is a retrospective analysis. The study included only patients with known pre-existing conditions (obesity, cardiac and neurological disease, coagulation disorder, anaemia) or post-surgical conditions who were treated with the Sonata® System for fibroid-related bleeding complaints at Academic Hospital Cologne Weyertal between January 2015 and March 2021. These patients were classified as high-risk patients. The fibroids were mostly determined due transvaginal sonography. Thirty patients were included, and 43 fibroids were determined.
Therapy with the Sonata® system could be performed without complications in all cases. In our analysis, improvement of fibroid-related symptoms was observed in 89% of cases.
The Sonata® System is on the one hand minimally invasive, uncomplicated and fast and on the other hand a successful method of fibroid therapy, which is particularly suitable for high-risk patients with various pre-existing conditions, for whom a minimally invasive, bloodless and short surgical procedure has great advantages.
展示经宫颈射频消融术（TRFA）在出血性疾病高危患者中的优势。
这是一项回顾性分析。研究仅包括已知存在预先存在的疾病（肥胖、心脏和神经系统疾病、凝血障碍、贫血）或手术后情况的患者，他们在 2015 年 1 月至 2021 年 3 月期间在科隆魏厄尔塔尔学术医院因肌瘤相关出血症状接受了 Sonata®系统治疗。这些患者被归类为高危患者。这些肌瘤主要通过阴道超声确定。共纳入 30 例患者，确定了 43 个肌瘤。
在所有病例中，Sonata®系统治疗均无并发症。在我们的分析中，89%的病例观察到肌瘤相关症状改善。
Sonata®系统一方面微创、简单、快速，另一方面是一种成功的肌瘤治疗方法，特别适用于存在各种预先存在疾病的高危患者，对于这些患者，微创、无血、手术时间短具有很大的优势。
